US2017322135A1PendingUtilityA1
Measurement of serum lipoproteins
Assignee: VAP DIAGNOSTICS LABORATORY INCPriority: Jun 16, 2012Filed: Jul 6, 2017Published: Nov 9, 2017
Est. expiryJun 16, 2032(~5.9 yrs left)· nominal 20-yr term from priority
Inventors:Krishnaji R. Kulkarni
G01N 2201/12G01N 2015/0065G01N 21/51G01N 2021/513G01N 15/06G01N 2015/0693G01N 15/01G01N 15/075
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Although a more accurate estimate of a person's risk of cardiovascular disease can be made on the basis of the number of lipoprotein particles per unit volume in the person's blood, current methods all rely on measuring the mass of lipoprotein cholesterol per unit volume. It has been discovered that a rapid and accurate lipoprotein particle count can be obtained by photometry. A method and apparatus are provided for measuring the number of lipoprotein particles in a sample using photometry.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method of measuring lipoprotein particle count in a sample from a subject, the method comprising:
a. separating a LDL fraction, a HDL fraction and a VLDL fraction in the sample by centrifugation; b. introducing the LDL fraction, the HDL fraction and the VLDL fraction into an apparatus for measuring the lipoprotein particle number; c. obtaining a photometric measurement in the LDL fraction; and d. calculating a particle count for the LDL fraction that is a function of the photometric measurement, wherein separation of the LDL fraction, the HDL fraction and the VLDL fraction is maintained during steps (b) and (c).
2 . The method of claim 1 further comprising:
a. obtaining a photometric measurement in at least the HDL fraction; and
b. calculating a particle count for the HDL fraction that is a function of the photometric measurement.
3 . The method of claim 1 further comprising:
a. obtaining a photometric measurement in at least the VLDL fraction; and
b. calculating a particle count for the VLDL fraction that is a function of the photometric measurement.
4 . The method of claim 1 further comprising:
a. obtaining a photometric measurement in the HDL fraction;
b. calculating a particle count for the HDL fraction that is a function of the photometric measurement;
c. obtaining a photometric measurement in the VLDL fraction; and
d. calculating a particle count for the VLDL fraction that is a function of the photometric measurement.
5 . The method of claim 1 , wherein the sample is contained in a sample vessel and the LDL fraction, the HDL fraction and the VLDL fraction are introduced into the apparatus in a descending order of density.
6 . The method of claim 1 , wherein the sample is a blood sample or a serum sample.
7 . A method of measuring lipoprotein particle count in a sample from a subject, the method comprising:
a. separating a LDL fraction, a HDL fraction, a Lp(a) fraction, an IDL fraction and a VLDL fraction in the sample by centrifugation; b. introducing the LDL fraction, the HDL fraction, the Lp(a) fraction, the IDL fraction and the VLDL fraction into an apparatus for measuring the lipoprotein particle number; c. obtaining a photometric measurement in at least one of the LDL fraction, the HDL fraction, the Lp(a) fraction, the IDL fraction and the VLDL fraction; and d. calculating a particle count for each fraction for which the photometric measurement was obtained wherein separation of the LDL fraction, the HDL fraction, the Lp(a) fraction, the IDL fraction and the VLDL fraction is maintained during steps (b) and (c).
8 . The method of claim 7 , wherein the at least one fraction is the LDL fraction and at least one fraction selected from the group consisting of the HDL fraction, the Lp(a) fraction, the IDL fraction and the VLDL fraction.
9 . The method of claim 7 , wherein the at least one fraction is the HDL fraction and at least one fraction selected from the group consisting of the LDL fraction, the Lp(a) fraction, the IDL fraction and the VLDL fraction.
10 . The method of claim 7 , wherein the at least one fraction is the IDL fraction and at least one fraction selected from the group consisting of the HDL fraction, the Lp(a) fraction, the LDL fraction and the VLDL fraction.
11 . The method of claim 7 , wherein the at least one fraction is the VLDL fraction and at least one fraction selected from the group consisting of the HDL fraction, the Lp(a) fraction, the LDL fraction and the IDL fraction.
12 . The method of claim 7 , wherein the at least one fraction is the Lp(a) fraction and at least one fraction selected from the group consisting of the HDL fraction, the IDL fraction, the LDL fraction and the VLDL fraction.
13 . The method of claim 7 , wherein the at least one fraction is the HDL fraction, the Lp(a) fraction, the LDL fraction, the IDL fraction and the VLDL fraction.
14 . The method of claim 7 , wherein the sample is contained in a sample vessel and the HDL fraction, the Lp(a) fraction, the LDL fraction, the IDL fraction and the VLDL fraction are introduced into the apparatus in a descending order of density.
15 . The method of claim 7 , wherein the sample is a blood sample or a serum sample.Join the waitlist — get patent alerts
Track US2017322135A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.